In addition to this, numerous novel serum indicators, such as DCP and AFP-L3, have been found to have higher diagnostic efficacy for HCC, yet these have to be widely verified in routine clinical practice (Zhou et al., 2021). The gene discussed is AFP; the disease is hepatocellular carcinoma.